A robust brain network for sustained attention from adolescence to adulthood that predicts later substance use.


Journal

bioRxiv : the preprint server for biology
Titre abrégé: bioRxiv
Pays: United States
ID NLM: 101680187

Informations de publication

Date de publication:
05 Apr 2024
Historique:
medline: 15 4 2024
pubmed: 15 4 2024
entrez: 15 4 2024
Statut: epublish

Résumé

Substance use, including cigarettes and cannabis, is associated with poorer sustained attention in late adolescence and early adulthood. Previous studies were predominantly cross-sectional or under- powered and could not indicate if impairment in sustained attention was a consequence of substance- use or a marker of the inclination to engage in such behaviour. This study explored the relationship between sustained attention and substance use across a longitudinal span from ages 14 to 23 in over 1,000 participants. Behaviours and brain connectivity associated with diminished sustained attention at age 14 predicted subsequent increases in cannabis and cigarette smoking, establishing sustained attention as a robust biomarker for vulnerability to substance use. Individual differences in network strength relevant to sustained attention were preserved across developmental stages and sustained attention networks generalized to participants in an external dataset. In summary, brain networks of sustained attention are robust, consistent, and able to predict aspects of later substance use. A robust brain network for sustained attention at age 14 predicts cigarette and cannabis use from ages 14 to 23.

Identifiants

pubmed: 38617224
doi: 10.1101/2024.04.03.587900
pmc: PMC11014614
pii:
doi:

Types de publication

Preprint

Langues

eng

Subventions

Organisme : NIDA NIH HHS
ID : R01 DA049238
Pays : United States
Organisme : NIMH NIH HHS
ID : R01 MH085772
Pays : United States
Organisme : NIA NIH HHS
ID : R56 AG058854
Pays : United States
Organisme : NIBIB NIH HHS
ID : U54 EB020403
Pays : United States

Références

J Cogn Neurosci. 2018 Feb;30(2):160-173
pubmed: 29040013
Nat Neurosci. 2016 Jan;19(1):165-71
pubmed: 26595653
Neuropsychology. 2005 Jan;19(1):88-96
pubmed: 15656766
Biol Psychiatry. 2017 Nov 1;82(9):687-694
pubmed: 28599833
Trends Cogn Sci. 2005 Feb;9(2):60-8
pubmed: 15668098
Neuroimage. 2023 Apr 15;270:119946
pubmed: 36801369
Psychol Sci. 2015 Sep;26(9):1497-510
pubmed: 26253551
J Psychopharmacol. 2011 Nov;25(11):1485-95
pubmed: 21300633
Int J Nurs Stud. 2014 Mar;51(3):511-21
pubmed: 24183474
Netw Neurosci. 2022 Feb 01;6(1):29-48
pubmed: 35350584
Front Neurosci. 2020 Jun 16;14:569
pubmed: 32612502
Neuropharmacology. 2019 Apr;148:178-188
pubmed: 30633928
Annu Rev Physiol. 1995;57:521-46
pubmed: 7778876
Biol Psychiatry. 2016 Apr 1;79(7):557-67
pubmed: 26858214
Addiction. 2021 Aug;116(8):2209-2219
pubmed: 33345423
Neuroimage. 2018 Feb 15;167:11-22
pubmed: 29122720
Proc Natl Acad Sci U S A. 2020 Feb 18;117(7):3797-3807
pubmed: 32019892
J Child Psychol Psychiatry. 2023 Aug;64(8):1159-1175
pubmed: 36990655
Addiction. 2012 Jul;107(7):1221-33
pubmed: 22300456
Am J Addict. 2012 Nov;21 Suppl 1:S14-9
pubmed: 23786505
Nature. 2014 Aug 14;512(7513):185-9
pubmed: 25043041
Nat Neurosci. 2012 Jun;15(6):920-5
pubmed: 22544311
Neuroimage Clin. 2021;30:102664
pubmed: 33872994
Drug Alcohol Depend. 1996 Sep;42(1):49-54
pubmed: 8889403
Neuron. 2018 Feb 21;97(4):769-785
pubmed: 29470969
Mol Psychiatry. 2021 Aug;26(8):4383-4393
pubmed: 31719641
Front Psychiatry. 2016 Jul 05;7:104
pubmed: 27458388
Biol Psychiatry. 2014 Jul 1;76(1):23-30
pubmed: 24138922
J Neurosci. 2000 Feb 1;20(3):1208-15
pubmed: 10648725
Addiction. 2022 Apr;117(4):934-945
pubmed: 34735038
Nat Neurosci. 2006 Aug;9(8):1050-6
pubmed: 16829955
Curr Opin Psychol. 2019 Oct;29:174-180
pubmed: 30986621
Neuroimage. 2018 Apr 1;169:395-406
pubmed: 29274748
Nat Neurosci. 2002 Feb;5(2):169-74
pubmed: 11802171
Subst Abuse. 2013 Oct 13;7:171-83
pubmed: 24151426
Cereb Cortex. 2019 Apr 1;29(4):1572-1583
pubmed: 29931116
Biochem Pharmacol. 2013 Sep 1;86(5):656-65
pubmed: 23831951
Drug Alcohol Depend. 2018 Oct 1;191:45-51
pubmed: 30077055
Am J Psychiatry. 2019 Feb 1;176(2):156-164
pubmed: 30606049
Eur Neuropsychopharmacol. 2007 Apr;17(5):339-51
pubmed: 17141485
Neurosci Biobehav Rev. 2020 Jan;108:358-369
pubmed: 31715191
Ther Adv Psychopharmacol. 2015 Jun;5(3):172-8
pubmed: 26199720
Mol Psychiatry. 2020 Dec;25(12):3413-3421
pubmed: 31427753
Drug Alcohol Depend. 2010 Apr 1;108(1-2):49-55
pubmed: 20047801
J Neurosci. 2000 Jun 15;20(12):4745-57
pubmed: 10844044
Arch Clin Neuropsychol. 2019 Jul 26;34(5):700-705
pubmed: 30295694
Transl Psychiatry. 2016 Mar 29;6:e769
pubmed: 27023175
Neuropsychopharmacology. 2009 Feb;34(3):759-66
pubmed: 18754005
Neuropsychology. 2012 Sep;26(5):541-50
pubmed: 22775342
Psychopharmacology (Berl). 2013 Mar;226(2):307-19
pubmed: 23138434
Science. 2007 Mar 2;315(5816):1267-70
pubmed: 17332411
Int J Neuropsychopharmacol. 2015 Jun 04;18(10):pyv061
pubmed: 26045474
Biol Psychiatry. 2014 Jul 1;76(1):4-5
pubmed: 24925889
Nat Protoc. 2017 Mar;12(3):506-518
pubmed: 28182017
Hum Brain Mapp. 2020 Nov;41(16):4459-4477
pubmed: 32964613
J Youth Adolesc. 1988 Apr;17(2):117-33
pubmed: 24277579
Cogn Affect Behav Neurosci. 2022 Dec;22(6):1432-1446
pubmed: 35676491
Neuropsychologia. 2009 Jan;47(2):591-4
pubmed: 18973765
Arch Gen Psychiatry. 2006 Sep;63(9):999-1008
pubmed: 16953002
Hum Brain Mapp. 2020 Dec 15;41(18):5356-5369
pubmed: 32969562
Neuroimage. 2013 Nov 15;82:403-15
pubmed: 23747961
Nature. 2016 Nov 16;539(7629):369-377
pubmed: 27853201
Biol Psychiatry. 2015 Nov 1;78(9):656-63
pubmed: 25092631
Annu Rev Psychol. 2020 Jan 4;71:79-106
pubmed: 31905114
Nat Neurosci. 2020 May;23(5):600-610
pubmed: 32251385
Semin Nucl Med. 2017 Jan;47(1):64-74
pubmed: 27987559

Auteurs

Classifications MeSH